loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 202319 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Perrigo Company plc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 PERRIGO R AND D (1)

    filter

    01 CAPSULE, DELAYED REL PELLETS;ORAL (1)

    filter

    01 OTC (1)

    filter

    01 LANSOPRAZOLE (1)

    filter

    01 No (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Ireland
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    LANSOPRAZOLE

    PDF Supplier PDF
    URL Supplier Web Content
    CAPSULE, DELAYED R...
    15MG
    2012-05-18
    202319
    LANSOPRAZOLE
    OTC
    No
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 202319

    Looking for FDA Orange Book APPLICATION 202319 1

    19

    Perrigo Company plc, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA.

    They are recognized for Perrigo Company is dedicated to making lives better by bringing Quality Affordable, Self-Care Products.

    One of their notable products is LANSOPRAZOLE, with a corresponding application number 202319.

    Regulatory Information OTC

    With a dosage strength 15MG

    Dosage Form Route CAPSULE, DELAYED REL PELLETS; ORAL

    Reference Listed Drug No

    Approved since 2012-05-18

    Post Enquiry
    POST ENQUIRY